160 related articles for article (PubMed ID: 35209173)
21. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
Shen K; Qi L; Stiff L
Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
[TBL] [Abstract][Full Text] [Related]
22. Peptidomimetics as potent and selective PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Shah K; Joharapurkar A; Shaikh M; Sairam KV
Med Chem; 2013 Aug; 9(5):660-71. PubMed ID: 23030658
[TBL] [Abstract][Full Text] [Related]
23. Past, present, and perspectives of protein N-terminal methylation.
Diaz K; Meng Y; Huang R
Curr Opin Chem Biol; 2021 Aug; 63():115-122. PubMed ID: 33839647
[TBL] [Abstract][Full Text] [Related]
24. Kinetic mechanism of protein N-terminal methyltransferase 1.
Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
[TBL] [Abstract][Full Text] [Related]
25. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and molecular simulation study of furoic peptidomimetic derivatives as potent aminopeptodase N inhibitors.
Gao M; He J; Xu W; Lai X; Liu F; Tu G
Pharmazie; 2018 Mar; 73(3):123-127. PubMed ID: 29544557
[TBL] [Abstract][Full Text] [Related]
27. Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction.
Nardone V; Lucarelli AP; Dalle Vedove A; Fanelli R; Tomassetti A; Belvisi L; Civera M; Parisini E
J Med Chem; 2016 May; 59(10):5089-94. PubMed ID: 27120112
[TBL] [Abstract][Full Text] [Related]
28. Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors.
Dong G; Yasgar A; Peterson DL; Zakharov A; Talley D; Cheng KC; Jadhav A; Simeonov A; Huang R
ACS Comb Sci; 2020 Aug; 22(8):422-432. PubMed ID: 32525297
[TBL] [Abstract][Full Text] [Related]
29. A mechanistic study on the inhibition of α-chymotrypsin by a macrocyclic peptidomimetic aldehyde.
Zhang X; Bruning JB; George JH; Abell AD
Org Biomol Chem; 2016 Aug; 14(29):6970-8. PubMed ID: 27349772
[TBL] [Abstract][Full Text] [Related]
30. Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction.
Zhou H; Liu L; Huang J; Bernard D; Karatas H; Navarro A; Lei M; Wang S
J Med Chem; 2013 Feb; 56(3):1113-23. PubMed ID: 23244744
[TBL] [Abstract][Full Text] [Related]
31. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
[TBL] [Abstract][Full Text] [Related]
32. Conformationally Constrained Peptidomimetics as Inhibitors of the Protein Arginine Methyl Transferases.
Knuhtsen A; Legrand B; Van der Poorten O; Amblard M; Martinez J; Ballet S; Kristensen JL; Pedersen DS
Chemistry; 2016 Sep; 22(39):14022-14028. PubMed ID: 27515561
[TBL] [Abstract][Full Text] [Related]
33. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.
Low KE; Ler S; Chen KJ; Campbell RL; Hickey JL; Tan J; Scully CC; Davies PL; Yudin AK; Zaretsky S
J Med Chem; 2016 Jun; 59(11):5403-15. PubMed ID: 27148623
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
Anglin JL; Deng L; Yao Y; Cai G; Liu Z; Jiang H; Cheng G; Chen P; Dong S; Song Y
J Med Chem; 2012 Sep; 55(18):8066-74. PubMed ID: 22924785
[TBL] [Abstract][Full Text] [Related]
35. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
Gokhale KM; Telvekar VN
Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
[TBL] [Abstract][Full Text] [Related]
36. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
37. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors.
Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
Bioorg Med Chem; 2017 Oct; 25(19):5077-5083. PubMed ID: 28359674
[TBL] [Abstract][Full Text] [Related]
39. Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L.
Basavapathruni A; Jin L; Daigle SR; Majer CR; Therkelsen CA; Wigle TJ; Kuntz KW; Chesworth R; Pollock RM; Scott MP; Moyer MP; Richon VM; Copeland RA; Olhava EJ
Chem Biol Drug Des; 2012 Dec; 80(6):971-80. PubMed ID: 22978415
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5.
Hoelz LVB; Zorzanelli BC; Azevedo PHRA; Passos SG; de Souza LR; Zani M; Pinheiro S; Puzer L; Dias LRS; Muri EMF
Eur J Med Chem; 2016 Apr; 112():39-47. PubMed ID: 26874743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
